Column Why the bio boom fell flat - The Korea JoongAng Daily

068760 Stock  KRW 54,800  1,900  3.35%   
About 62% of Celltrion Pharm's investor base is looking to short. The analysis of current outlook of investing in Celltrion Pharm suggests that many traders are alarmed regarding Celltrion Pharm's prospects. The current market sentiment, together with Celltrion Pharm's historical and current headlines, can help investors time the market. In addition, many technical investors use Celltrion Pharm stock news signals to limit their universe of possible portfolio assets.
  
Column Why the bio boom fell flat The Korea JoongAng Daily

Read at news.google.com
Google News at Macroaxis
  

Celltrion Pharm Fundamental Analysis

We analyze Celltrion Pharm's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Celltrion Pharm using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Celltrion Pharm based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Revenue

Revenue Comparative Analysis

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Peers

Trending Equities

S  1.67   
0%
63.0%
TGT  1.49   
0%
56.0%
CVX  1.29   
0%
49.0%
INTC  1.16   
0%
44.0%
UPS  0.62   
0%
23.0%
AA  0.56   
0%
21.0%
BBY  0.43   
0%
16.0%
T  0.26   
0%
9.0%
IBM  0.05   
0%
1.0%
WFC  0.07   
2.0%
0%
MET  0.12   
4.0%
0%
HD  0.14   
5.0%
0%
C  0.64   
24.0%
0%
AAL  1.08   
41.0%
0%
CVS  1.49   
56.0%
0%
AAPL  2.62   
100.0%
0%

Complementary Tools for Celltrion Stock analysis

When running Celltrion Pharm's price analysis, check to measure Celltrion Pharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celltrion Pharm is operating at the current time. Most of Celltrion Pharm's value examination focuses on studying past and present price action to predict the probability of Celltrion Pharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celltrion Pharm's price. Additionally, you may evaluate how the addition of Celltrion Pharm to your portfolios can decrease your overall portfolio volatility.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Bonds Directory
Find actively traded corporate debentures issued by US companies
CEOs Directory
Screen CEOs from public companies around the world
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities